Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression

Detalhes bibliográficos
Autor(a) principal: Silva, Soraia
Data de Publicação: 2021
Outros Autores: Bicker, Joana, Falcão, Amílcar, Fortuna, Ana
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/105337
https://doi.org/10.3390/pharmaceutics13111975
Resumo: Scientific evidence that circadian rhythms affect pharmacokinetics and pharmacodynamics has highlighted the importance of drug dosing-time. Circadian oscillations alter drug absorption, distribution, metabolism, and excretion (ADME) as well as intracellular signaling systems, target molecules (e.g., receptors, transporters, and enzymes), and gene transcription. Although several antidepressant drugs are clinically available, less than 50% of depressed patients respond to first-line pharmacological treatments. Chronotherapeutic approaches to enhance the effectiveness of antidepressants are not completely known. Even so, experimental results found until this day suggest a positive influence of drug dosing-time on the efficacy of depression therapy. On the other hand, antidepressants have also demonstrated to modulate circadian rhythmicity and sleep-wake cycles. This review aims to evidence the potential of chronotherapy to improve the efficacy and/or safety of antidepressants. It includes pre-clinical and clinical studies that demonstrate the relevance of determining the most appropriate time of administration for antidepressant drugs. In parallel, their positive influence on the resynchronization of disrupted circadian rhythms is also herein discussed. It is expected that this review will promote the investigation of chronotherapy for the treatment of depression, contribute to a better understanding of the relationship between antidepressants and circadian rhythms, and consequently promote the development of new therapeutics.
id RCAP_c0375dd3c09823302dc9fd7a7d3e99fb
oai_identifier_str oai:estudogeral.uc.pt:10316/105337
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depressionantidepressantcircadian rhythmchronopharmacokineticschrono-pharmacodynamicschronotoxicologydepressionclinical studiesScientific evidence that circadian rhythms affect pharmacokinetics and pharmacodynamics has highlighted the importance of drug dosing-time. Circadian oscillations alter drug absorption, distribution, metabolism, and excretion (ADME) as well as intracellular signaling systems, target molecules (e.g., receptors, transporters, and enzymes), and gene transcription. Although several antidepressant drugs are clinically available, less than 50% of depressed patients respond to first-line pharmacological treatments. Chronotherapeutic approaches to enhance the effectiveness of antidepressants are not completely known. Even so, experimental results found until this day suggest a positive influence of drug dosing-time on the efficacy of depression therapy. On the other hand, antidepressants have also demonstrated to modulate circadian rhythmicity and sleep-wake cycles. This review aims to evidence the potential of chronotherapy to improve the efficacy and/or safety of antidepressants. It includes pre-clinical and clinical studies that demonstrate the relevance of determining the most appropriate time of administration for antidepressant drugs. In parallel, their positive influence on the resynchronization of disrupted circadian rhythms is also herein discussed. It is expected that this review will promote the investigation of chronotherapy for the treatment of depression, contribute to a better understanding of the relationship between antidepressants and circadian rhythms, and consequently promote the development of new therapeutics.MDPI2021-11-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/105337http://hdl.handle.net/10316/105337https://doi.org/10.3390/pharmaceutics13111975eng1999-4923Silva, SoraiaBicker, JoanaFalcão, AmílcarFortuna, Anainfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-02-17T11:07:13Zoai:estudogeral.uc.pt:10316/105337Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:21:55.794260Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
title Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
spellingShingle Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
Silva, Soraia
antidepressant
circadian rhythm
chronopharmacokinetics
chrono-pharmacodynamics
chronotoxicology
depression
clinical studies
title_short Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
title_full Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
title_fullStr Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
title_full_unstemmed Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
title_sort Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
author Silva, Soraia
author_facet Silva, Soraia
Bicker, Joana
Falcão, Amílcar
Fortuna, Ana
author_role author
author2 Bicker, Joana
Falcão, Amílcar
Fortuna, Ana
author2_role author
author
author
dc.contributor.author.fl_str_mv Silva, Soraia
Bicker, Joana
Falcão, Amílcar
Fortuna, Ana
dc.subject.por.fl_str_mv antidepressant
circadian rhythm
chronopharmacokinetics
chrono-pharmacodynamics
chronotoxicology
depression
clinical studies
topic antidepressant
circadian rhythm
chronopharmacokinetics
chrono-pharmacodynamics
chronotoxicology
depression
clinical studies
description Scientific evidence that circadian rhythms affect pharmacokinetics and pharmacodynamics has highlighted the importance of drug dosing-time. Circadian oscillations alter drug absorption, distribution, metabolism, and excretion (ADME) as well as intracellular signaling systems, target molecules (e.g., receptors, transporters, and enzymes), and gene transcription. Although several antidepressant drugs are clinically available, less than 50% of depressed patients respond to first-line pharmacological treatments. Chronotherapeutic approaches to enhance the effectiveness of antidepressants are not completely known. Even so, experimental results found until this day suggest a positive influence of drug dosing-time on the efficacy of depression therapy. On the other hand, antidepressants have also demonstrated to modulate circadian rhythmicity and sleep-wake cycles. This review aims to evidence the potential of chronotherapy to improve the efficacy and/or safety of antidepressants. It includes pre-clinical and clinical studies that demonstrate the relevance of determining the most appropriate time of administration for antidepressant drugs. In parallel, their positive influence on the resynchronization of disrupted circadian rhythms is also herein discussed. It is expected that this review will promote the investigation of chronotherapy for the treatment of depression, contribute to a better understanding of the relationship between antidepressants and circadian rhythms, and consequently promote the development of new therapeutics.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-21
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/105337
http://hdl.handle.net/10316/105337
https://doi.org/10.3390/pharmaceutics13111975
url http://hdl.handle.net/10316/105337
https://doi.org/10.3390/pharmaceutics13111975
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1999-4923
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134109536092161